跳至主要内容
临床试验/NCT03776318
NCT03776318已完成不适用

A Multicenter, Randomized, Follow-up Study to Evaluate the Long-Term Safety of Clonidine Micropellets for the Treatment of Pain Associated With Lumbosacral Radiculopathy in Adults

Sollis Therapeutics, Inc.25 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2018年11月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
100
试验地点
25
主要终点
Change in Average and Worst NRS from Day 60 post injection to 12 months post injection

研究概览

简要总结

Long-term follow-up study to evaluate the safety of clonidine micropellets up to 12 months post injection.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject who have successfully completed all STX-015-18-01 study related activities, are reconfirmed to be eligible and have signed informed consent to participate.

排除标准

  • Subjects who, in the opinion of the investigator, have demonstrated significant non-compliance with STX-015-18-01 study procedures.
  • Subjects who were unblinded to their treatment in STX-015-18-01 study.

研究组 & 干预措施

Safety Group

STX-015-18-01 Clonidine Micropellet long-term safety follow-up

干预措施: Long-Term Safety Follow-up (Drug)

Sham Control

STX-015-18-01 Sham control long-term safety follow-up

干预措施: Long-Term Safety Follow-up (Drug)

结局指标

主要结局

Change in Average and Worst NRS from Day 60 post injection to 12 months post injection

时间窗: 10 months from completing Day 60 of the STX-015-18-01 study

Difference in NRS pain scores from Day 60 of STX-015-18-01 to month 12 post injection

次要结局

  • Incidence of Surgeries(12 months from day of injection)
  • Incidence of Invasive treatment received(12 months from day of injection)
  • Number of Prescription medications taken(12 months from day of injection)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (25)

Loading locations...

相似试验

Long-Term Follow-up Safety of Clonidine Micropellets | 临床试验